The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

Digycyl-Lysine Antibody, clone GX41

Department:

Inventor:


This is a monoclonal antibody which recognizes a diglycine modified lysine, the trypsinized remnant of ubiquitination. The recognition does not depend on neighboring backbone amino acid sequences. It has been shown to specifically detect peptides derived from the ubiquitinated portion of proteins.